In a newly-released case study, Medpace #neuropsychiatry experts discuss the challenges and strategies of a Phase II major depressive disorder (#MDD) trial, including overcoming concerns about potential misuse of the study drug, mitigating the impact of placebo response, reducing patient burden, and more. Download the MDD #CaseStudy to explore successful approaches to streamlining psychiatry clinical development: https://lnkd.in/gGKZPb4t
Good point!
Felix Perez, CEO Research Director
1moGreat insights from Medpace’s neuropsychiatry experts! The case study on Phase II MDD trials sounds incredibly valuable for addressing key challenges. #MDD #ClinicalDevelopment